Bradykinin release and inactivation in brain of rats submitted to an experimental model of Alzheimer's disease-Reference-Cited by-同舟云学术

Bradykinin release and inactivation in brain of rats submitted to an experimental model of Alzheimer's disease

Published:2006-12 Issue:12 Volume:27 Page:3363-3369
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Iores-Marçal Lígia M.,Viel Tânia A.,Buck Hudson Sousa,Nunes Viviane A.,Gozzo Andrezza J.,Cruz-Silva Ilana,Miranda Antonio,Shimamoto Kazuaki,Ura Nobuyuki,Araujo Mariana S.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference32 articles.

1. Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment;Ahmed;Neurochem Int,2005

2. Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer's disease;Aoyagi;Experientia,1990

3. Activation of complement and contact system in Alzheimer's disease;Bergamaschini;Mech Ageing Dev,2001

4. Bioregulation of kinins: kallikreins, kininogens and kininases;Bhoola;Pharmacol Rev,1992

5. Renal tissue kallikrein, plasma renin and plasma aldosterone in renal hypertension;Carretero;Acta Physiol Lat Am,1974

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Potential Drug Targets Involved in Inflammation Contributing to Alzheimer’s Disease Progression;Pharmaceuticals;2024-01-20

2. Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective;Journal of Cellular and Molecular Medicine;2023-10-17

3. Angiotensin Receptor Blockers and Cognition: a Scoping Review;Current Hypertension Reports;2023-09-21

4. Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model;Pharmaceuticals;2020-10-01

5. Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients;Neurobiology of Disease;2020-06